Difference between revisions of "Julie Gerberding"
(revolving door) |
m (Text replacement - " has served on " to " was on ") |
||
(2 intermediate revisions by one other user not shown) | |||
Line 6: | Line 6: | ||
|birth_date=22 August 1955 | |birth_date=22 August 1955 | ||
|alma_mater=Case Western Reserve University | |alma_mater=Case Western Reserve University | ||
+ | |description=Approved [[Merck]] vaccine [[Gardasil]] as CDC Director, salary $172,000. Then made around $25 million from stock sales when working for Merck. | ||
|death_date= | |death_date= | ||
|death_place= | |death_place= | ||
− | |constitutes= | + | |constitutes=civil servant |
|employment={{job | |employment={{job | ||
|title=Director of the Centers for Disease Control and Prevention | |title=Director of the Centers for Disease Control and Prevention | ||
Line 17: | Line 18: | ||
|acting=Yes | |acting=Yes | ||
|end=3 July 2002}} | |end=3 July 2002}} | ||
− | }}'''Dr Julie Gerberding''' | + | }}'''Dr Julie Gerberding''' served as the director of the [[Centers for Disease Control|U.S. Centers for Disease Control and Prevention]] (CDC) for then to be rewarded with a position as executive vice president for strategic communications, global public policy & population health and the chief patient officer at [[Merck & Co.|Merck]].<ref>https://archive.today/20201229235326/https://www.merck.com/leadership/julie-l-gerberding-m-d-m-p-h/</ref> |
+ | |||
+ | Gerberding became a nationally-recognized figure during the [[2001 anthrax attacks]] in the [[United States]]. As the Acting Deputy Director of National Center for Infectious Diseases, Gerberding was a prominent spokeswoman for the CDC during daily briefings regarding the attacks and aftermath.<ref>https://archive.today/20201230000704/https://www.sandiegouniontribune.com/sdut-med-cdc-director-011109-2009jan11-story.html</ref> | ||
+ | |||
+ | ==AIDS research== | ||
+ | During her medical residency at [[San Francisco General Hospital]], Gerberding treated some of the first hospitalized [[HIV/AIDS|AIDS]] patients.<ref>https://archive.today/20210606150717/https://www.usatoday.com/in-depth/news/health/2021/06/05/40-years-after-first-reported-aids-cases-treatments-better-vaccine/7471281002/</ref> She completed several studies on the risks of HIV to healthcare workers, created guidelines to prevent their infections, and established a treatment and research unit focused on HIV/AIDS cases among the urban poor.<ref>https://archive.today/20201230033235/https://www.cidrap.umn.edu/news-perspective/2002/07/julie-gerberding-named-director-cdc</ref> | ||
==Revolving Door== | ==Revolving Door== | ||
− | In late [[2009]], Gerberding became president of [[Big Pharma]] corporation [[Merck]]'s vaccines division<ref>http://www.fiercebiotech.com/special-reports/julie-gerberding-top-women-biotech-2013</ref>. According to form 4 SEC filings, between 2015 and 2020, Gerberding sold $23,968,010 in Merck stock.<ref>https://pl.wallmine.com/people/5297/julie-l-gerberding#complete-history</ref> Since July of 2016, she | + | [[Merck]]’s [[Gardasil vaccine]] was approved and mandated by the CDC when Gerberding was the director of the CDC. |
+ | She went from about $172,000 in salary to around $25 million in compensation from stock sales at Merck and CERN.<ref>https://childrenshealthdefense.org/vaccine-secrets/video-chapters/massive-money-mayhem-round/</ref> | ||
+ | |||
+ | In late [[2009]], Gerberding became president of [[Big Pharma]] corporation [[Merck]]'s vaccines division<ref>http://www.fiercebiotech.com/special-reports/julie-gerberding-top-women-biotech-2013</ref>. According to form 4 SEC filings, between 2015 and 2020, Gerberding sold $23,968,010 in Merck stock.<ref>https://pl.wallmine.com/people/5297/julie-l-gerberding#complete-history</ref> Since July of 2016, she was on the board of directors at the [[Cerner Corporation]], a health care technology corporation.[<ref>Cerner Corporation, 2019 Annual Report, p. 2.</ref> On July 17, 2020 she sold 36,285 units of CERN stock worth $2,902,800. | ||
+ | |||
{{SMWDocs}} | {{SMWDocs}} | ||
==References== | ==References== | ||
{{reflist}} | {{reflist}} | ||
− |
Latest revision as of 16:00, 24 January 2023
Julie Gerberding (civil servant) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Born | 22 August 1955 | ||||||||||||||||||||
Nationality | US | ||||||||||||||||||||
Alma mater | Case Western Reserve University | ||||||||||||||||||||
Member of | Covid Commission Planning Group, The Commons Project | ||||||||||||||||||||
Approved Merck vaccine Gardasil as CDC Director, salary $172,000. Then made around $25 million from stock sales when working for Merck.
|
Dr Julie Gerberding served as the director of the U.S. Centers for Disease Control and Prevention (CDC) for then to be rewarded with a position as executive vice president for strategic communications, global public policy & population health and the chief patient officer at Merck.[1]
Gerberding became a nationally-recognized figure during the 2001 anthrax attacks in the United States. As the Acting Deputy Director of National Center for Infectious Diseases, Gerberding was a prominent spokeswoman for the CDC during daily briefings regarding the attacks and aftermath.[2]
AIDS research
During her medical residency at San Francisco General Hospital, Gerberding treated some of the first hospitalized AIDS patients.[3] She completed several studies on the risks of HIV to healthcare workers, created guidelines to prevent their infections, and established a treatment and research unit focused on HIV/AIDS cases among the urban poor.[4]
Revolving Door
Merck’s Gardasil vaccine was approved and mandated by the CDC when Gerberding was the director of the CDC. She went from about $172,000 in salary to around $25 million in compensation from stock sales at Merck and CERN.[5]
In late 2009, Gerberding became president of Big Pharma corporation Merck's vaccines division[6]. According to form 4 SEC filings, between 2015 and 2020, Gerberding sold $23,968,010 in Merck stock.[7] Since July of 2016, she was on the board of directors at the Cerner Corporation, a health care technology corporation.[[8] On July 17, 2020 she sold 36,285 units of CERN stock worth $2,902,800.
Events Participated in
Event | Start | End | Location(s) | Description |
---|---|---|---|---|
Clade X | 15 May 2018 | 15 May 2018 | A pandemic/biowarfare preparation exercise by Johns Hopkins Center for Health Security. Held May 2018. | |
WEF/Annual Meeting/2008 | 23 January 2008 | 27 January 2008 | World Economic Forum Switzerland | At the 2008 summit, Klaus Schwab called for a coordinated approach, where different 'stakeholders' collaborate across geographical, industrial, political and cultural boundaries." |
WEF/Annual Meeting/2011 | 26 January 2011 | 30 January 2011 | World Economic Forum Switzerland | 2229 guests in Davos, with the theme: "Shared Norms for the New Reality". |
WEF/Annual Meeting/2012 | 25 January 2012 | 29 January 2012 | Switzerland | 2113 guests in Davos |
WEF/Annual Meeting/2013 | 23 January 2013 | 27 January 2013 | World Economic Forum Switzerland | 2500 mostly unelected leaders met to discuss "leading through adversity" |
WEF/Annual Meeting/2017 | 17 January 2017 | 20 January 2017 | World Economic Forum Switzerland | 2950 known participants, including prominently Bill Gates. "Offers a platform for the most effective and engaged leaders to achieve common goals for greater societal leadership." |
WEF/Annual Meeting/2019 | 22 January 2019 | 25 January 2019 | World Economic Forum Switzerland | "The reality is that we are in a Cold War [against China] that threatens to turn into a hot one." |
WEF/Annual Meeting/2020 | 21 January 2020 | 24 January 2020 | World Economic Forum Switzerland | This mega-summit of the world's ruling class and their political and media appendages happens every year, but 2020 was special, as the continuous corporate media coverage of COVID-19 started more or less from one day to the next on 20/21 January 2020, coinciding with the start of the meeting. |
References
- ↑ https://archive.today/20201229235326/https://www.merck.com/leadership/julie-l-gerberding-m-d-m-p-h/
- ↑ https://archive.today/20201230000704/https://www.sandiegouniontribune.com/sdut-med-cdc-director-011109-2009jan11-story.html
- ↑ https://archive.today/20210606150717/https://www.usatoday.com/in-depth/news/health/2021/06/05/40-years-after-first-reported-aids-cases-treatments-better-vaccine/7471281002/
- ↑ https://archive.today/20201230033235/https://www.cidrap.umn.edu/news-perspective/2002/07/julie-gerberding-named-director-cdc
- ↑ https://childrenshealthdefense.org/vaccine-secrets/video-chapters/massive-money-mayhem-round/
- ↑ http://www.fiercebiotech.com/special-reports/julie-gerberding-top-women-biotech-2013
- ↑ https://pl.wallmine.com/people/5297/julie-l-gerberding#complete-history
- ↑ Cerner Corporation, 2019 Annual Report, p. 2.